Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides

Applied and Environmental Microbiology

Volumn 77, Issue 14, 2011, Pages 4878-4885

  Chen, Xi ^a   Zhang, Mi ^b   Zhou, Chunhui ^c   Kallenbach, Neville R ^c   Ren, Dacheng ^a,b  

^a SYRACUSE UNIVERSITY   (United States)

^b Syracuse University   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL PEPTIDE; BACTERIAL POPULATION; BIOFILM CELLS; CHRONIC INFECTION; EFFECTIVE THERAPY; HIGH CONCENTRATION; LINEAR PEPTIDES; OFLOXACIN; PERSISTER CELLS; PERSISTERS;

AMINO ACIDS; BACTERIOLOGY; BIOFILMS; CYTOLOGY; DENDRIMERS; ESCHERICHIA COLI; PEPTIDES;

CELLS;

AMPICILLIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ARGINYL TRYPTOPHYL ARGININE; ARGINYL-TRYPTOPHYL-ARGININE; OFLOXACIN; OLIGOPEPTIDE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL DISEASE; BACTERIUM; BIOFILM; CATION; DISEASE TREATMENT; MEMBRANE; MICROBIAL ACTIVITY; PEPTIDE; TOLERANCE; VIABILITY;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CELL MEMBRANE; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGICAL EXAMINATION; PLANKTON;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; CELL MEMBRANE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; OLIGOPEPTIDES; PLANKTON;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 79961095617     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02440-10     Document Type: Article

References (51)

1. Anwar, H., M. K. Dasgupta, and J. W. Costerton. 1990. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother. 34:2043-2046.
2. Ashby, M., J. Neale, S. Knott, and I. Critchley. 1994. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J. Antimicrob. Chemother. 33:443-452.
3. Balaban, N. Q., J. Merrin, R. Chait, L. Kowalik, and S. Leibler. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
4. Bigger, J. W. 1944. The bactericidal action of penicillin on Staphylococcus pyogenes. Ir. J. Med. Sci. 19:553-568.
5. Bigger, J. W. 1944. Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244:497-500.
6. Black, D. S., B. Irwin, and H. S. Moyed. 1994. Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 176:4081-4091.
7. Black, D. S., A. J. Kelly, M. J. Mardis, and H. S. Moyed. 1991. Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J. Bacteriol. 173:5732-5739.
8. Brown, M. R. W., D. G. Allison, and P. Gilbert. 1988. Resistance of bacterial biofilms to antibiotics a growth-rate related effect? J. Antimicrob. Chemother. 22:777-783.
9. Chen, C. Y., G. W. Nace, and P. L. Irwin. 2003. A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J. Microbiol. Methods 55:475-479.
10. Coates, A., Y. Hu, R. Bax, and C. Page. 2002. The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Dis. 1:895-910.
11. Costerton, J. W., et al. 1987. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41:435-464.
12. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
13. De Groote, V. N., et al. 2009. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 297:73-79.
14. Dörr, T., M. Vuli, and K. Lewis. 2010. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8:e1000317.
15. Drenkard, E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 5:1213-1219.
16. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
17. Gallo, R. L., M. Murakami, T. Ohtake, and M. Zaiou. 2002. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110:823-831.
18. Gefen, O., and N. Q. Balaban. 2009. The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol. Rev. 33:704-717.
19. Gilbert, P., J. Das, and I. Foley. 1997. Biofilm susceptibility to antimicrobials. Adv. Dent. Res. 11:160-167.
20. Giuliani, A., G. Pirri, and S. F. Nicoletto. 2007. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Bio. 2:1-33.
21. Hall-Stoodley, L., J. W. Costerton, and P. Stoodley. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
22. Hancock, R. E. W., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24: 1551-1557.
23. Hansen, S., K. Lewis, and M. Vulic. 2008. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents Chemother. 52:2718-2726.
24. Harrison, J. J., et al. 2009. The chromosomal toxin gene yafQ is a determinant of multidrug tolerance for Escherichia coli growing in a biofilm. Antimicrob. Agents Chemother. 53:2253-2258.
25. Heydorn, A., et al. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146:2395-2407.
26. Hou, S., et al. 2010. Effects of Trp- and Arg-containing antimicrobial-peptide structure on inhibition of Escherichia coli planktonic growth and biofilm formation. Appl. Environ. Microbiol. 76:1967-1974.
27. Hou, S., et al. 2009. Antimicrobial dendrimer active against Escherichia coli biofilms. Bioorg. Med. Chem. Lett. 19:5478-5481.
28. Hu, Y., and A. R. M. Coates. 2005. Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli. FEMS Microbiol. Lett. 243:117-124.
29. Huang, H. W. 2006. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 1758:1292-1302.
30. Kaufmann, S., R. Medzhitov, and S. Gordon (ed.). 2004. The innate immune response to infection. ASM Press, Washington, DC.
31. Keren, I., N. Kaldalu, A. Spoering, Y. Wang, and K. Lewis. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
32. Keren, I., D. Shah, A. Spoering, N. Kaldalu, and K. Lewis. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
33. Kim, Y., and T. Wood. 2010. Toxins Hha and CspD and small RNA regulator Hfq are involved in persister cell formation through MqsR in Escherichia coli. Biochem. Biophys. Res. Commun. 391:209-213.
34. Korch, S. B., T. A. Henderson, and T. M. Hill. 2003. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p) ppGpp synthesis. Mol. Microbiol. 50:1199-1213.
35. Korch, S. B., and T. M. Hill. 2006. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188:3826-3836.
36. Lewis, K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56.
37. Liu, Z., et al. 2007. Length effects in antimicrobial peptides of the (RW)n series. Antimicrob. Agents Chemother. 51:597-603.
38. Liu, Z., et al. 2007. Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. Chembiochem 8:2063-2065.
39. Loose, C., K. Jensen, I. Rigoutsos, and G. Stephanopoulos. 2006. A linguistic model for the rational design of antimicrobial peptides. Nature 443:867-869.
40. Marshall, S. H. 2003. Antimicrobial peptides: a natural alternative to chemical antibiotics and a potential for applied biotechnology. Electron. J. Biotechnol. 6:271-284.
41. Moyed, H., and K. Bertrand. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768-775.
42. Moyed, H. S., and S. H. Broderick. 1986. Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 166:399-403.
43. Mulcahy, L. R., J. L. Burns, S. Lory, and K. Lewis. 2010. Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192:6191-6199.
44. Nataro, J. P., M. J. Blaser, and S. Cunningham-Rundles (ed.). 2000. Persistent bacterial infections. ASM Press, Washington, DC.
45. Ojha, A. K., et al. 2008. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69:164-174.
46. O'Toole, G. A. 2002. Microbiology: a resistance switch. Nature 416:695-696.
47. Rotem, E., et al. 2010. Regulation of phenotypic variability by a thresholdbased mechanism underlies bacterial persistence. Proc. Natl. Acad. Sci. 107: 12541-12546.
48. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
49. Spoering, A. L., M. Vulic, and K. Lewis. 2006. GlpD and PlsB participate in persister cell formation in Escherichia coli. J. Bacteriol. 188:5136-5144.
50. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
51. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.